Results from a 20-week phase 1b clinical trial showed that a once-weekly dose of 2.4 mg cagrilintide in combination with an equal dose of semaglutide, collectively termed cagrisema, achieved up to 17.1% weight reduction in the obese population
Arterial stiffness in heart failure with preserved ejection fraction: is this a new predisposing factor?, Current Problems in Cardiology, 51 , 10, (103386), (2026)
Pancreatitis is also a rare but serious condition that remains an important monitored safety concern
If you want to dig deeper into Perspectum's expertise in this area, reach out to our Pharma Solutions team at the link below to see how we use quantitative MRI to work across the entire development pipeline and help clinical trial sponsors differentiate their treatments
Some compounding pharmacies have used these salt forms in the past because they were easier to source